| Item 5.02. |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Departure of Chief Financial Officer
On July 1, 2026, American Eagle Outfitters, Inc. (the “Company”) announced that Michael Mathias will transition from his positions as Executive Vice President – Chief Financial Officer and Principal Financial Officer of the Company to a non-officer role as Strategic Advisor to the Chief Executive Officer of the Company, Jay Schottenstein, effective August 3, 2026 (the “Transition Date”).
The Company thanks Mr. Mathias for his contributions and leadership during his tenure as Chief Financial Officer.
Appointment of Chief Financial Officer
On June 30, 2026, the Board of Directors of the Company (the “Board”) appointed Ravi Thanawala to serve as Executive Vice President – Chief Financial Officer and Principal Financial Officer of the Company, effective as of the Transition Date.
Mr. Thanawala previously served as Chief Financial Officer and President, North America for Papa John’s International, Inc. Prior to that, he held various leadership positions at Nike, Inc., including Chief Financial Officer of Converse and Chief Financial Officer of Nike North America. Prior to Nike, Inc., Mr. Thanawala spent eight years at ANN INC. with progressively increasing responsibilities in finance and operations.
There are no arrangements or understandings between Mr. Thanawala and any other persons pursuant to which he was selected as an officer of the Company, and there are no transactions involving Mr. Thanawala requiring disclosure under Item 404(a) of Regulation S-K.
Compensatory Arrangements
In connection with his appointment, the Company entered into an offer letter with Mr. Thanawala on June 27, 2026, which will become effective as of the Transition Date. The offer letter provides for (i) an annual base salary of $1,000,000; and (ii) eligibility to earn an annual incentive compensation bonus with a target opportunity equal to 100% of eligible earnings (i.e., base salary actually paid during the applicable fiscal year) and a maximum opportunity of 200% of eligible earnings.
The offer letter also provides that, in lieu of the ordinary course annual equity grant in respect of the Company’s fiscal year 2026, upon the commencement of his employment, Mr. Thanawala will be granted (i) a stock option award with a grant date value of $750,000, which will vest in equal annual installments over three years from the grant date; (ii) a time-based restricted stock unit award covering a number of shares of the Company’s common stock determined by dividing $500,000 by the closing price of a share of the Company’s common stock on the grant date, which will vest in equal annual installments over three years from the grant date; and (iii) a performance-based restricted stock unit award with a target grant date value of $1,250,000, which will vest based on the Company’s achievement of the applicable performance goals over a three year performance period, with the vesting level ranging from 0% to 150% of target. Following fiscal year 2026, Mr. Thanawala will be eligible to participate in the Company’s annual equity grant program, with the size and composition of such awards to be determined in the discretion of the Compensation Committee of the Board.
In addition, under the offer letter, Mr. Thanawala will be granted a sign on award in consideration of his equity awards, bonus and other compensation forfeited from his prior employer in connection with the commencement of his employment with the Company, consisting of a (i) cash bonus of $1,000,000, payable in two equal installments (with the first installment payable within the first two months following the commencement of his employment and the second installment payable in February 2027) and, pursuant to a repayment letter, subject to prorated repayment if Mr. Thanawala voluntarily terminates his employment or is terminated by the Company for gross misconduct or proven dishonesty within 24 months following the payment date of each installment; and (ii) a restricted stock unit award covering a number of shares of the Company’s common stock determined by dividing $1,500,000 by the closing price of a share of the Company’s common stock on the grant date, which will vest in two equal installments on the first and second anniversary of the grant date.
The offer letter further provides that, upon a termination of Mr. Thanawala’s employment by the Company without cause, subject to his execution and non-revocation of a customary release of claims, he will be entitled to receive cash severance in the form of continued base salary payments for up to 12 months and Company-paid COBRA premiums for continued health, dental and vision coverage during such period. The offer letter also provides that Mr. Thanawala will enter into the Company’s standard confidentiality, non-competition and intellectual property agreement, pursuant to which he will be subject to customary restrictive covenants, including a perpetual confidentiality covenant, a 12-month post-termination non-solicitation covenant with respect to the Company’s employees, and a 12-month post-termination non-competition covenant that may be enforced by the Company in its discretion. If the Company elects to enforce the non-competition covenant, Mr. Thanawala will be entitled to receive continued payment of his base salary for the duration of the restricted period (or portion thereof) that is not waived by the Company (which will be offset by any severance paid by the Company and will not be payable during any period of employment with another employer).
Additionally, the offer letter provides that Mr. Thanawala will be eligible to participate in the Company’s employee stock purchase plan, 401(k) plan, deferred compensation plan, relocation benefits (which are subject to a repayment letter providing for prorated repayment if Mr. Thanawala voluntarily terminates his employment or is terminated for violations of the Company’s Code of Ethics, Workplace Culture Policy or Work Rules within the 24-month period following the date of such repayment letter) and health and welfare benefit programs on terms generally applicable to similarly situated executive officers.